(Press-News.org) According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common than previously known. The discovery deepens understanding of the symptoms of this memory disorder and emphasises the importance of taking epileptic seizures into account in the treatment and monitoring of patients.
Coordinated by Neurocenter Finland, this major project by the University of Eastern Finland and the University of Oulu examined the prevalence of epilepsy in patients with FTD. The research dataset is one of the largest in the world, and the results have been published in the prestigious JAMA Neurology journal.
Epilepsy occurred years before the FTD diagnosis
Epilepsy is known to be associated with Alzheimer’s disease, for example, but data on the on the connection between FTD and epilepsy remains scarce. The newly published study fills this information gap and shows that epilepsy is considerably more common in patients with FTD than previously estimated.
The study analysed patient data from the university hospitals of Kuopio and Oulu from the period 2010–2021. Out of a total of 12,490 medical records, the study identified 245 patients with FTD and 1,326 patients with Alzheimer’s disease. In addition to examining the prevalence of epilepsy in these patients, the prevalence was also examined in healthy controls.
“Our results show that epilepsy is considerably more common among those with FTD than those with Alzheimer’s disease or in healthy controls,” says Doctoral Researcher Annemari Kilpeläinen, the first author of the research article and a medical specialist in neurology.
“It is noteworthy that epilepsy occurred in some patients with FTD already ten years before their dementia diagnosis, and it was more common in all the examined stages of the disease than previous international studies have reported.”
The prevalence of epilepsy was assessed at several time points from ten years before to five years after the dementia diagnosis. In patients with FTD, the prevalence of epilepsy increased over time, and five years after the diagnosis approximately 11% had epilepsy. In addition to epilepsy diagnoses, medications used for epilepsy were more common in patients with FTD, which strengthens the reliability of the results.
Epilepsy might be left undiagnosed
Diagnosing epilepsy in patients with FTD may be challenging as the symptoms of the disease may resemble epileptic seizures. This may lead to underdiagnosis and delays in treatment. However, untreated epilepsy can significantly worsen patients’ condition.
“Identifying epilepsy is important because its treatment can improve patients’ functional capacity and quality of life. Knowledge about the association between epilepsy and FTD raises new research questions: do these diseases share some pathophysiological mechanisms and could some FTD symptoms be caused by alterations in the specific electrical systems of the brain”, says the project’s principal investigator, Associate Professor and Director of UEF Brain Research Unit Eino Solje.
An extensive research project brings together different fields of science
The recently published study is part of an extensive project that combines exceptionally extensive real-life patient data with different kinds of unique registers. The project involves a strong cooperation between the University of Oulu and the University of Eastern Finland as well as different fields of science, including between researchers in the fields of medicine and law. Kuopio University Hospital and Oulu University Hospital are part of the international European Reference Network EpiCARE and recognised centres in the field of epilepsy treatment and research.
END
Epilepsy is more common in patients with frontotemporal dementia than expected
2025-06-02
ELSE PRESS RELEASES FROM THIS DATE:
Pre-operative THP leads to a pCR in two-thirds of early-stage HER2+ ER- breast cancer patients
2025-06-02
Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is currently being evaluated in the CompassHER2 pCR trial (EA1181, NCT04266249) by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). While longer follow-up is needed to assess long-term outcomes, pathologic complete response (pCR) rates and predictors of ...
Immune system discovery reveals potential solution to Alzheimer’s
2025-06-02
A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer’s and other neurodegenerative diseases.
University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts to fix DNA damage in the brain. Their research reveals that an immune molecule called STING drives the formation of the harmful plaques and protein ...
Salamanders suffering from rising temperatures
2025-06-02
FRANKFURT. Habitat loss, diseases, pollution, and climate change are already massively affecting amphibians – frogs, salamanders, and the caecilians native to tropical regions. The new study from the Institute for Ecology, Evolution and Diversity shows that extreme weather events serve as an additional stress factor, further intensifying this crisis. For this purpose, the scientists analyzed global weather data from the past 40 years. They compared regions with significantly increased heat waves, droughts, and cold spells with the geographical ...
It’s not too late to start eating better for your brain
2025-06-02
As the U.S. population ages and dementia cases rise, many people are asking whether it is possible to prevent this devastating disease. According to a new study, the answer may be on your plate: People who followed a dietary pattern known as the MIND diet were significantly less likely to develop Alzheimer’s disease or related forms of dementia.
The MIND diet, which stands for Mediterranean-DASH Intervention for Neurodegenerative Delay, combines the Mediterranean diet with the blood pressure-lowering DASH (Dietary Approaches to Stop Hypertension) diet and also emphasizes proven brain-healthy ...
Study finds seniors are money savvy – until dementia sets in
2025-06-02
Older adults are quite aware of their financial abilities – and these abilities actually improve with age – that is, until dementia sets in, according to new research from Binghamton University, State University of New York.
From paying bills to making change, knowing how to handle money is necessary to live and thrive in society. But what happens as we get older? Do our financial abilities decline and if so, are we even aware of our own shortcomings?
To examine this, a team of researchers led by Binghamton University psychologist ...
Synthetic compound shows promise against multidrug resistance
2025-06-02
Highlights:
Infections by antimicrobial resistant (AMR) pathogens are a leading cause of death worldwide, with more than 1 million deaths annually, highlighting the need for new treatments.
Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens.
Infuzide works against known, problematic gram-positive pathogens.
In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.
Washington, D.C.—Antimicrobial ...
Researchers recreate ancient Egyptian blues
2025-06-02
PULLMAN, Wash.--A team of Washington State University-led researchers has recreated the world's oldest synthetic pigment, called Egyptian blue, which was used in ancient Egypt about 5,000 years ago.
Reporting in the journal, NPJ Heritage Science, the researchers used a variety of raw materials and heating times to develop 12 recipes for the pigments, providing useful information for archaeologists and conservation scientists who study the ancient Egyptian materials. The work was done in collaboration with Carnegie Museum of ...
Immunotherapy before surgery improves lung cancer survival in global clinical trial led by Irish cancer specialist
2025-06-02
Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved long term survival compared to those who received chemotherapy alone, at 5 years after completing treatment. Prof. Patrick Forde of the Trinity St. James’s Cancer Institute (TSJCI), Trinity College Dublin School of Medicine presented the findings at the American ...
S2302 Pragmatica-Lung reports out as model for faster, leaner, more representative trials
2025-06-02
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary question, finding that the investigational combination it tested did not significantly extend overall survival compared to standard of care treatments.
Importantly, the phase 3 trial’s rapid development and implementation, coupled with its successful enrollment of a group of patients broadly representative of the larger U.S. population, establish Pragmatica-Lung as a paradigm-shifting model for the design and conduct of future large randomized studies.
Results will be presented ...
New Venus observation mission - World's first long-term planetary cubesat study by Korea’s Institute for Basic Science and NanoAvionics
2025-06-02
Daejeon, South Korea, and Vilnius, Lithuania, 2 June 2025 – Kongsberg NanoAvionics (NanoAvionics), a leading small satellite bus manufacturer and mission integrator, has been selected by the Institute for Basic Science (IBS) in South Korea to build the first CubeSat for the world’s first long-term planetary science campaign which will use a series of CubeSats to monitor Venus from low Earth orbit.
This long-term Venus observation initiative, the CLOVE project (Chasing the Long-term Variability of Our Nearest Neighbor Planet ...